Society for Clinical Research Sites' Global Impact Partner Program Experiences Rapid Growth, Welcomes Four New Members
SCRS Welcomes INC Research, inVentiv Health, Novartis and Sanofi
Leading sponsor and CRO organizations continue to join the Society for Clinical Research Sites' (SCRS) Global Impact Partner (GIP) program at a rapid pace. Since April 1, INC Research, inVentiv Health, Novartis and Sanofi have joined the SCRS GIP program. From its inception only one year ago, the initiative has quickly grown to 25 leading organizations.
Global Impact Partners participate on the SCRS Global Impact Board at an executive level and work in tandem with the SCRS Leadership Council. They serve as strategic partners and help set key initiatives for the Society to elevate site performance and enhance site sustainability.
"Industry continues to respond enthusiastically to a unified community of sites, and to the concept that sites should no longer be the underrepresented partner in the clinical research process," said SCRS President Christine Pierre. "Sites represent a critical link between industry and patient, and have an incredible stake in every step of clinical discovery. Leveraging this unified voice will provide processes and operational efficiencies to improve sustainability for everyone involved in clinical research."
The newest Global Impact Partners join 21 other world-class organizations who have embraced collaboration as a key to site sustainability. The SCRS Global Impact Partners now include:
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
